Back to News
Market Impact: 0.1
Tonix Names Englese Chief Commercial Officer To Expand TONMYA Reach
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
Tonix Pharmaceuticals Holding Corp. promoted Thomas Englese, MBA, to Chief Commercial Officer, effective immediately. The announcement is a routine executive appointment with no financial metrics, strategic guidance, or product updates disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
TNXP0.15
More News
- Apple's $2000+ iPhone, Oil Gain Stokes Inflation Fear | Bloomberg Businessweek Daily 9/8/2026
- Stock Movers: Chime, Stryker, Compass Pathways (Podcast)
- Cholesterol drug setback casts doubt over multibillion-dollar race
- Kaplan Fox Continues to Alert Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Class Action Deadline on November 2, 2026
- Attacks Halt Saudi Energy Sites, Novartis Drops Most in 6 Years | The Opening Trade 9/8/2026
- Pharma major plummets over 10% after third trial disappointment in a week